OR WAIT 15 SECS
Covance recognized for providing superior vaccine services to biopharmaceutical industry.
Princeton, NJ-May 5, 2008-Covance (www.covance.com), the world’s largest publicly traded contract research organization, today announced that it has won the “Best Contract Research Organization (CRO)” award at the 2008 World Vaccine Congress, held recently in Washington, DC. As part of the Vaccine Industry Excellence (ViE) awards, the Best CRO award is designed to highlight the importance of contract research services within the vaccine industry. This award recognizes Covance as best-in-class when it comes to providing services that support vaccine development.
“This recognition reaffirms our commitment to providing vaccine services that encompass all phases of development,” said Wendel Barr, chief operating officer for Covance. “We understand that each vaccine is unique, and therefore we offer services and experience-including scientific, technical, and regulatory expertise-across different types of vaccines to help guide our customers through the complexities of vaccine development.”
A panel of international judges selected Covance based on the company’s state-of-the-art facilities, vaccine services, and superior customer relations that together help biopharmaceutical companies speed vaccine development. The ViE Awards were created to honor and generate public recognition of the efforts, accomplishments, and positive contributions of organizations and individuals in the global vaccine industry.
The global vaccine market generated sales of $13.5 billion in 2006 and is expected to reach $24.8 billion by 2013, according to a 2007 report published by Wood Mackenzie, a research and consulting firm.